Assessment of the Value of Nivolumab Plus Ipilimumab for Treating Microsatellite Instability-High/Mismatch Repair Deficiency Metastatic Colorectal Cancer: Indirect Treatment Comparison and Cost-Effectiveness Analysis
- DOI
- 10.1007/s12325-026-03787-x
- Published
- 2026-09-08
- Container
- Advances in Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-026-03787-x,
title = {Assessment of the Value of Nivolumab Plus Ipilimumab for Treating Microsatellite Instability-High/Mismatch Repair Deficiency Metastatic Colorectal Cancer: Indirect Treatment Comparison and Cost-Effectiveness Analysis},
author = {Lytske J. Bakker and Katharina Nickel and Zoe Cheah and Elizabeth A. Sigworth and Bodille P. M. Blomaard and Reginald Villacorta and Lixian Jin and Kiran Davé and Claire L. Simons and Craig Bennison},
year = {2026},
journal = {Advances in Therapy},
doi = {10.1007/s12325-026-03787-x},
url = {https://doi.org/10.1007/s12325-026-03787-x}
}RIS
TY - JOUR TI - Assessment of the Value of Nivolumab Plus Ipilimumab for Treating Microsatellite Instability-High/Mismatch Repair Deficiency Metastatic Colorectal Cancer: Indirect Treatment Comparison and Cost-Effectiveness Analysis AU - Lytske J. Bakker AU - Katharina Nickel AU - Zoe Cheah AU - Elizabeth A. Sigworth AU - Bodille P. M. Blomaard AU - Reginald Villacorta AU - Lixian Jin AU - Kiran Davé AU - Claire L. Simons AU - Craig Bennison PY - 2026 JO - Advances in Therapy DO - 10.1007/s12325-026-03787-x UR - https://doi.org/10.1007/s12325-026-03787-x ER -
APA
Bakker, L. J., Nickel, K., Cheah, Z., Sigworth, E. A., Blomaard, B. P. M., Villacorta, R., Jin, L., Davé, K., Simons, C. L., & Bennison, C. (2026). Assessment of the Value of Nivolumab Plus Ipilimumab for Treating Microsatellite Instability-High/Mismatch Repair Deficiency Metastatic Colorectal Cancer: Indirect Treatment Comparison and Cost-Effectiveness Analysis. Advances in Therapy. https://doi.org/10.1007/s12325-026-03787-x
Source records
- crossref · retrieved 2026-09-25T20:26:54.484Z